IFNG and neoplasm: OxPt/SN38and αPD-L1 combination treatment increases tumor-infiltratinglymphocytes and antigen-specific IFN-γ-producing T cells inthe spleens and repolarizes M2 macrophages into M1 macrophages toactivate the tumor immune microenvironment.